White House announces contract to produce millions of at-home COVID-19 tests
The White House COVID-19 response team at a virtual press briefing Monday announced the Defense Department and the Department of Health and Human Services struck a $230 million deal with the Australian company Ellume to make millions of at-home, over-the-counter COVID-19 tests.
Dr. Andy Slavitt, a senior adviser to White House COVID-19 response team, said the self-performed, over-the-counter test kits can detect COVID-19 with roughly 95% accuracy within 15 minutes and will be available for about $30.
"They can be used if you feel symptoms of COVID-19 and also for screening for people without symptoms, so they can safely go to work, school, into events that are appropriate for people ages two and older," Slavitt said.
He said the test is performed in a mid-turbinate nasal swab which, he said, "basically means it's less invasive than the long nasal pharyngeal swab that people may have seen on the news."
The test user puts the sample into a digital analyzer which can send test results to a smartphone in about 15 minutes. Results would not have to be sent out to a lab.
Citing the contract, Slavitt said Ellume will be able to scale their production to manufacture more than 19 million test kits per month by the end of 2021, 8.5 billion of which are guaranteed to the U.S. government.
Asked how a $30 at home test fit into White House's equity goal and for screening people regularly, Slavitt said the unit costs can only come down with mass production.